SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Q: When is the next results date for Sudeep Pharma?

The next results date for Sudeep Pharma is scheduled for 19 December 2025.

Q: Why is Sudeep Pharma Ltd falling/rising?

As of 18-Apr, Sudeep Pharma Ltd's stock price is rising, currently at 647.00, reflecting an increase of 12.7 points or 2.0%. This upward movement can be attributed to several factors. Over the past week, the stock has gained 6.01%, significantly outperforming the Sensex, which only increased by 1.22% during the same period. Additionally, the stock has shown a consistent upward trend, having gained for the last four consecutive days.Today, Sudeep Pharma reached an intraday high of Rs 649, marking a rise of 2.32%. The stock is also trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating strong bullish momentum. However, it is worth noting that there has been a decline in investor participation, with delivery volume dropping by 61.72% compared to the 5-day average, which could suggest a potential concern for future trading activity. Despite this, the stock remains liquid enough for trading, supporting its current price increase. Overall, the combination of recent performance and technical indicators contributes to the stock's rising price.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

83.44 k (34.56%) Volume

Shareholding (Mar 2026)

FII

1.55%

Held by 13 FIIs

DII

10.76%

Held by 10 DIIs

Promoter

76.15%

When is the next results date for Sudeep Pharma?

17-Dec-2025

The next results date for Sudeep Pharma is 19 December 2025.

View full answer

Why is Sudeep Pharma Ltd falling/rising?

19-Apr-2026

As of 18-Apr, Sudeep Pharma Ltd's stock price is rising to 647.00, up 2.0% and outperforming the Sensex. Despite a decline in investor participation, the stock shows strong bullish momentum and remains liquid for trading.

View full answer

Which are the latest news on Sudeep Pharma?

19-Apr-2026

No latest news for Sudeep Pharma found.

Compare Sudeep Pharma with Similar Stocks

Marksans Pharma Blue Jet Health Shilpa Medicare

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 7,125 Cr (Small Cap)

P/E

48.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.10

Return on Equity

19.15%

Price to Book

9.93

Revenue and Profits:

Net Sales:

172 Cr

(Quarterly Results - Dec 2025)

Net Profit:

47 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

10.42%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Sudeep Pharma for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Apr-2026 | Source : BSE

Submission of Certificate under Regulation 74 (5) of SEBI (DP) Regulations.

Closure of Trading Window

26-Mar-2026 | Source : BSE

Intimation for Closure of Trading Window w.e.f. 1st April 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Mar-2026 | Source : BSE

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per below details: Date & Time: 23rd March 2026 (12:00 pm onwards) Nature of Meeting: 1x1 / Group Meeting Place: Mumbai Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Kindly note that changes may happen due to exigencies on the part of Participants / Company.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

37.35

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

24.13%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.67%

ROCE (avg)

23.00%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

10.09

EV to EBIT

41.16

EV to EBITDA

38.87

EV to Capital Employed

9.24

EV to Sales

14.71

PEG Ratio

Dividend Yield

ROCE (Latest)

22.44%

ROE (Latest)

19.15%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (6.19%)

FIIs

Held by 13 FIIs (1.55%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

3.11%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "90.28",
          "val2": "87.88",
          "chgp": "2.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.61",
          "val2": "30.87",
          "chgp": "-4.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.63",
          "val2": "2.03",
          "chgp": "-68.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "26.87",
          "val2": "29.74",
          "chgp": "-9.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.80%",
          "val2": "35.13%",
          "chgp": "-2.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.06",
          "val2": "168.40",
          "chgp": "-0.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.27",
          "val2": "60.03",
          "chgp": "2.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.47",
          "val2": "1.99",
          "chgp": "74.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "54.95",
          "val2": "41.98",
          "chgp": "30.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.46%",
          "val2": "35.65%",
          "chgp": "0.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "258.34",
          "val2": "251.88",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.88",
          "val2": "86.49",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "3.24",
          "chgp": "26.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "81.82",
          "val2": "62.61",
          "chgp": "30.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.18%",
          "val2": "34.34%",
          "chgp": "0.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.81",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "95.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.99%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

90.28

87.88

2.73%

Operating Profit (PBDIT) excl Other Income

29.61

30.87

-4.08%

Interest

0.63

2.03

-68.97%

Exceptional Items

0.00

Standalone Net Profit

26.87

29.74

-9.65%

Operating Profit Margin (Excl OI)

32.80%

35.13%

-2.33%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.73% vs 9.62% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -9.65% vs 18.02% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

168.06

168.40

-0.20%

Operating Profit (PBDIT) excl Other Income

61.27

60.03

2.07%

Interest

3.47

1.99

74.37%

Exceptional Items

0.00

Standalone Net Profit

54.95

41.98

30.90%

Operating Profit Margin (Excl OI)

36.46%

35.65%

0.81%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

258.34

251.88

2.56%

Operating Profit (PBDIT) excl Other Income

90.88

86.49

5.08%

Interest

4.10

3.24

26.54%

Exceptional Items

0.00

Standalone Net Profit

81.82

62.61

30.68%

Operating Profit Margin (Excl OI)

35.18%

34.34%

0.84%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

356.73

Operating Profit (PBDIT) excl Other Income

131.96

Interest

4.81

Exceptional Items

0.00

Standalone Net Profit

95.75

Operating Profit Margin (Excl OI)

36.99%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Sudeep Pharma Ltd

Sudeep Pharma Ltd

Small Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available